About iPSCAPE

 To create a global, harmonized patient registry that ensures the safe, transparent, and long-term tracking of patients receiving iPSC-based therapies, accelerating clinical adoption and regulatory alignment. 

 The iPScape team is in the early stages of building support within ISCT and the broader iPSC community to establish a global patient registry for iPSC-based therapies. 

 Key stakeholders include regulatory agencies (FDA, EMA, PMDA, Health Canada), clinicians, industry leaders (biotech, pharma, and manufacturing companies), academic researchers, patient advocacy groups, standards organizations, and healthcare policymakers. 

 We will be reaching out to representatives from each of these groups across different countries to ensure a collaborative and internationally harmonized approach.